Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics Sana Biotechnology has a new $50 million tool in its toolbox. Sana signed an agreement with Beam Therapeutics for non-exclusive… Read More
Sana joins Nasdaq with blockbuster $587M IPO Sana Biotechnology raised $587.5 million in an initial public offering, a significant cash haul that the 3-year-old Seattle company will… Read More
Sana Biotechnology boosts IPO range, looks to raise $517 million Editor’s note: Sana Biotechnology priced shares on Wednesday evening, raising $587.5 million. See full story here. Sana Biotechnology —… Read More
Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M Sana Biotechnology CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the… Read More
Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the… Read More
Startup of the Year nominees share tips for success — cast your vote now for the GeekWire Awards A quick gander at the GeekWire 200, our index of Pacific Northwest startups, shows the density of up-and-coming tech companies… Read More
